Nx GEN Sequencing Glaucoma Test sale cost 5730 AED
Ophthalmology Eyes Vision Panel NGS Genetic Test sale cost 5410 AED Ophthalmology Eyes Vision Panel NGS Genetic Test 6,010 د.إ Original price was: 6,010 د.إ.5,410 د.إCurrent price is: 5,410 د.إ.
Sale!

Nx GEN Sequencing Glaucoma Test

Original price was: 6,370 د.إ.Current price is: 5,730 د.إ.

-10%

The “Nx Gen Sequencing Glaucoma Test” offered by DNA Labs UAE represents a cutting-edge approach in the early detection and management of glaucoma, a group of eye conditions that can lead to vision loss by damaging the optic nerve, often associated with increased pressure within the eye. Utilizing next-generation sequencing (NGS) technology, this test analyzes multiple genes known to be linked with the development of glaucoma. By examining an individual’s genetic predisposition, the test provides valuable insights into the risk factors, helping in the formulation of personalized prevention and treatment plans.

The cost of the Nx Gen Sequencing Glaucoma Test is 5730 AED. This investment allows patients to access a comprehensive analysis of their genetic makeup with respect to glaucoma, enabling early intervention strategies that can significantly alter the course of the disease. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test stands as a testament to the advancements in genetic research and its application in enhancing patient care in ophthalmology.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nx GEN SEQUENCING GLAUCOMA Test

Components

  • ACVR1
  • ASB10
  • BEST1
  • CANT1
  • COL18A1
  • CYP1B1
  • FOXC1
  • LMX1B
  • LOXL1
  • LTBP2
  • MYOC
  • NTF4
  • OPTN
  • PAX6
  • PITX2
  • PITX3
  • SBF2
  • WDR36

Price

5730.0 AED

Sample Condition

Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE.

Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Report Delivery

Sample Daily by 9 am; Report 45 Working days

Method

NGS, Sanger sequencing

Test Type

Glaucoma

Doctor

Ophthalmologist

Test Department

MOLECULAR DIAGNOSTICS

Pre Test Information

Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Test Details

Glaucoma is a group of eye diseases that damage the optic nerve, which is responsible for transmitting visual information from the eye to the brain. It is the leading cause of irreversible blindness worldwide. Early detection and treatment can help prevent vision loss, but currently available diagnostic tests have limitations. Next-generation sequencing (NGS) is a powerful tool that can analyze multiple genes simultaneously and detect genetic variations that may contribute to glaucoma. NGS-based glaucoma testing can help identify individuals who are at risk of developing the disease and enable early intervention. NGS-based glaucoma testing can also provide valuable information for personalized treatment plans and genetic counseling. It can help identify the specific genetic mutations that are responsible for glaucoma in an individual, which can guide the selection of appropriate medications and surgical interventions. Overall, NGS-based glaucoma testing has the potential to improve the accuracy of glaucoma diagnosis and management, leading to better outcomes for patients.

Test Name Nx GEN SEQUENCING GLAUCOMA Test
Components ACVR1, ASB10, BEST1, CANT1, COL18A1, CYP1B1, FOXC1, LMX1B, LOXL1, LTBP2, MYOC, NTF4, OPTN, PAX6, PITX2, PITX3, SBF2, WDR36
Price 5730.0 AED
Sample Condition Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE.Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery Sample Daily by 9 am; Report 45 Working days
Method NGS, Sanger sequencing
Test type Glaucoma
Doctor Ophthalmologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details

Glaucoma is a group of eye diseases that damage the optic nerve, which is responsible for transmitting visual information from the eye to the brain. It is the leading cause of irreversible blindness worldwide. Early detection and treatment can help prevent vision loss, but currently available diagnostic tests have limitations.

Next-generation sequencing (NGS) is a powerful tool that can analyze multiple genes simultaneously and detect genetic variations that may contribute to glaucoma. NGS-based glaucoma testing can help identify individuals who are at risk of developing the disease and enable early intervention.

NGS-based glaucoma testing can also provide valuable information for personalized treatment plans and genetic counseling. It can help identify the specific genetic mutations that are responsible for glaucoma in an individual, which can guide the selection of appropriate medications and surgical interventions.

Overall, NGS-based glaucoma testing has the potential to improve the accuracy of glaucoma diagnosis and management, leading to better outcomes for patients.

SKU: TEST-817 Category:

Related products